Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
of the disorder and the resulting splicing dysfunction, and to establish appropriate mouse models, with the ultimate goal of developing an RNA-targeted therapy. This position offers the opportunity to work at the
-
University of British Columbia Department of Surgery | Northern British Columbia Fort Nelson, British Columbia | Canada | about 2 months ago
multidisciplinary team Experience in research using relevant techniques will be an asset: cell or gene therapy culture ;Animal models of immune disease; Genome engineering Lipid nanoparticle technologies; Synthetic
-
shaping the future of regenerative medicine and Advanced Therapy Medicinal Products (ATMPs)? ATMPs are transforming healthcare by harnessing the power of cells, genes, and engineered tissues to repair
-
sequencing technologies and multi-omic approaches for the identification of novel disease-associated genes or pathogenic mechanisms, as well as for the functional characterization of detected genetic variants
-
gene therapy products as well as pharmaceutical products. The role is responsible for the implementation of new manufacturing processes, methods, and instruments while ensuring the highest of quality in
-
Medicines Agency, as well as several academic clinical trials, including gene therapy and drug repurposing strategies. The group also investigates DNA repair genes as potential therapeutic targets
-
to develop a novel universal therapy for maintaining hemostasis in patients at risk for bleeding. Objectives Computational de novo design of VHH and scFv binders to blood coagulation factors such as factor Xa
-
. The main role is to support in vivo studies of the effects of gene therapies in preclinical mouse models. This includes animal husbandry, colony management, drug treatments, behavioural assays, genotyping
-
University of North Carolina at Chapel Hill | Chapel Hill, North Carolina | United States | 15 days ago
received from appropriately accredited institutions. Management Preferences Experience with early-phase or first-in-human clinical trials. Oncology or cell/gene therapy experience preferred. Prior experience
-
University of North Carolina at Chapel Hill | Chapel Hill, North Carolina | United States | about 17 hours ago
received from appropriately accredited institutions. Management Preferences Experience with early-phase or first-in-human clinical trials. Oncology or cell/gene therapy experience preferred. Prior experience